These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 18898

  • 1. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE.
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract] [Full Text] [Related]

  • 2. Antagonism of the effects of chlorpromazine and morphine on dopamine metabolism by GABA.
    Lahti RA, Losey EG.
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):31-40. PubMed ID: 4811457
    [No Abstract] [Full Text] [Related]

  • 3. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.
    Kääriäinen I.
    Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):393-400. PubMed ID: 989685
    [No Abstract] [Full Text] [Related]

  • 4. The effect of baclofen and aminooxyacetic acid on the action of drugs stimulating the dopaminergic system.
    Sypniewska M.
    Pol J Pharmacol Pharm; 1978 Sep; 30(6):755-66. PubMed ID: 573471
    [Abstract] [Full Text] [Related]

  • 5. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H, Engberg G, Pileblad E.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [Abstract] [Full Text] [Related]

  • 6. The effect of baclofen and aminoxyacetic acid on catalepsy in the rat.
    Sypniewska M.
    Pol J Pharmacol Pharm; 1978 Jul; 30(4):441-9. PubMed ID: 33368
    [Abstract] [Full Text] [Related]

  • 7. Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
    Waldmeier PC, Maitre L.
    Eur J Pharmacol; 1978 Jan 15; 47(2):191-200. PubMed ID: 23298
    [Abstract] [Full Text] [Related]

  • 8. Taurine and its derivatives alter brain dopamine metabolism similarly to GABA in mice and rats.
    Ahtee L, Vahala ML.
    Prog Clin Biol Res; 1985 Jan 15; 179():331-41. PubMed ID: 4059218
    [No Abstract] [Full Text] [Related]

  • 9. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 15; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 10. Biochemical effects of baclofen (beta-parachlorophenyl-GABA) on the dopamine and the noradrenaline in the rat brain.
    Andén NE, Wachtel H.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb 15; 40(2):310-20. PubMed ID: 576560
    [Abstract] [Full Text] [Related]

  • 11. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P, Corrodi H, Fuxe K, Olson L.
    Brain Res; 1972 Oct 27; 45(2):507-24. PubMed ID: 4404488
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine.
    Kelly PH, Moore KE.
    Neuropharmacology; 1978 Mar 27; 17(3):169-74. PubMed ID: 643163
    [No Abstract] [Full Text] [Related]

  • 13. Effects of baclofen and gamma-hydroxybutyrate on rat striatal and mesolimbic 5-HT metabolism.
    Waldmeier PC, Fehr B.
    Eur J Pharmacol; 1978 May 15; 49(2):177-84. PubMed ID: 658133
    [Abstract] [Full Text] [Related]

  • 14. [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].
    Waldmeier PC, Maître L.
    Arzneimittelforschung; 1978 May 15; 28(9):1507-8. PubMed ID: 582544
    [Abstract] [Full Text] [Related]

  • 15. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A, Parenti M, Cattabeni F, Maggi A, De Angelis L, Monduzzi M, Racagni G.
    Adv Biochem Psychopharmacol; 1978 May 15; 19():363-71. PubMed ID: 696464
    [No Abstract] [Full Text] [Related]

  • 16. Gamma-aminobutyric acid (GABAB) receptor-mediated inhibition of tyrosine hydroxylase activity in the striatum of rat.
    Arias-Montaño JA, Martínez-Fong D, Aceves J.
    Neuropharmacology; 1991 Oct 15; 30(10):1047-51. PubMed ID: 1684645
    [Abstract] [Full Text] [Related]

  • 17. Various dose-dependent influences of apomorphine on the acetylcholine turnover in striatum and mesolimbic areas of rat brain.
    Langnickel R, Bluth R, Oelssner W.
    Biomed Biochim Acta; 1983 Oct 15; 42(7-8):937-46. PubMed ID: 6651810
    [Abstract] [Full Text] [Related]

  • 18. [Dopamine metabolism and the GABA level in the structures of the nigrostriatal and mesolimbic systems of the rat brain in experimental pathology of higher nervous activity].
    Saul'skaia NB.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988 Oct 15; 38(6):1145-51. PubMed ID: 3245325
    [Abstract] [Full Text] [Related]

  • 19. Some aspects of dopamine in the central nervous system.
    Carlsson A.
    Adv Neurol; 1974 Oct 15; 5():59-68. PubMed ID: 4155236
    [No Abstract] [Full Text] [Related]

  • 20. Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.
    Walters JR, Bunney BS, Roth RH.
    Adv Neurol; 1975 Oct 15; 9():273-84. PubMed ID: 167566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.